The role of Raf-1 kinase in diabetic retinopathy

Expert Opinion on Therapeutic Targets

Volumn 15, Issue 4, 2011, Pages 357-364

  Mohammad, Ghulam ^a   Kowluru, Renu A ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Diabetes; diabetic retinopathy; Raf kinase; retina

Indexed keywords

3 (3,5 DIBROMO 4 HYDROXYBENZYLIDENE) 1,3 DIHYDRO 5 IODO 2 INDOLONE; ANTISENSE OLIGONUCLEOTIDE; ENZYME INHIBITOR; ICO 007; ISIS 325568; RAF PROTEIN; RAS PROTEIN; SORAFENIB; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTISENSE THERAPY; DIABETIC RETINOPATHY; ENZYME INHIBITION; HUMAN; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RETINA CAPILLARY; RETINA NEOVASCULARIZATION; REVIEW; SIGNAL TRANSDUCTION;

DIABETIC RETINOPATHY; ENZYME INHIBITORS; EYE; HUMANS; MAP KINASE SIGNALING SYSTEM; MOLECULAR TARGETED THERAPY; PROTO-ONCOGENE PROTEINS C-RAF; RETINA; RETINAL VESSELS; SIGNAL TRANSDUCTION;

EID: 79952642466     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.2011.553604     Document Type: Review

References (75)

1. Klein R, Klein BE, Jensen SC, et al. The relation of socioeconomic factors to the incidence of proliferative diabetic retinopathy and loss of vision. Ophthalmology 1994;101:68-76 (Pubitemid 24044145)
2. Chew EY. Epidemiology of diabetic retinopathy. Hosp Med 2003;64:396-9 (Pubitemid 38938383)
3. Porta M, Bandello F. Diabetic retinopathy: a clinical update. Diabetologia 2002;45:1617-34 (Pubitemid 35478131)
4. Frank RN. Diabetic retinopathy. N Engl J Med 2004;350:48-58 (Pubitemid 38032183)
5. Diabetes control and complications trial research group. Early worsening of diabetic retinopathy in the diabetes control and complication trial. Arch Ophthalmol 1998;116:874-86
6. UK Prospective Diabetes Study (UKPDS) group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-53
7. Mizutani M, Gerhardinger C, Lorenzi M. Muller cell changes in human diabetic retinopathy. Diabetes 1998;47:455-9
8. Barber AJ, Lieth E, Khin SA, et al. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998;102:783-91 (Pubitemid 28399611)
9. Kern TS, Tang J, Mizutani M, et al. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 2000;41:3972-8
10. Kowluru RA, Odenbach S. Effect of long-term administration of alpha lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes 2004;53:3233-8 (Pubitemid 39564500)
11. Davis MD, Norton EWD, Myers FL. The Airlie House classification of diabetic retinopathy. In: Goldberg MF, Fine SL, editors, Symposium on the Treatment of Diabetic Retinopathy. US Public Health Service Publishers, 1969; Public Health Service Publication, Washington DC; 1890. p. 7-22
12. Bresnick GH, Davis MD, Myers FL, et al. Clinicopathologc correlations in diabetic retinopathy. II. Clinical and histologic appearances of retinal capillary microaneurysms. Arch Ophthalmol 1977;95:1215-20 (Pubitemid 8143730)
13. Engerman RL. Pathogenesis of diabetic retinopathy. Diabetes 1989;38:1203-6 (Pubitemid 19247412)
14. Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 1996;97:2883-90 (Pubitemid 26197103)
15. Joussen AM, Poulaki V, Tsujikawa A, et al. Suppression of diabetic retinopathy with angiopoietin-1. Am J Pathol 2002;160:1683-93 (Pubitemid 34525648)
16. Kowluru RA, Kowluru A, Chakrabarti S, et al. Potential contributory role of H-Ras, a small G-protein, in the development of retinopathy in diabetic rats. Diabetes 2004;53:775-83 (Pubitemid 38270649)
17. El-Remessy AB, Bartoli M, Platt DH, et al. Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration. J Cell Sci 2005;118:243-52 (Pubitemid 40277119)
18. Rayappa S, Kowluru RA. Role of Raf-1 kinase in diabetes-induced accelerated apoptosis of retinal capillary cells. Int J Biomed Sci 2008;4:20-8 (Pubitemid 351663734)
19. Du Y, Tang J, Li G, et al. Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function. Invest Ophthalmol Vis Sci 2010;51:2158-64
20. Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 2010;106:1319-31
21. Kowluru RA, Kanwar M. Translocation of H-Ras and its implications in the development of diabetic retinopathy. Biochem Biophys Res Commun 2009;387:461-6
22. Schubbert S, Bollag G, Shannon K. Deregulated Ras signaling in developmental disorders: new tricks for an old dog. Curr Opin Genet Dev 2007;17:15-22 (Pubitemid 46109294)
23. Omerovic J, Prior IA. Compartmentalized signaling: ras proteins and signaling nanoclusters. FEBS J 2009;276:1817-25
24. Leicht DT, Balan V, Kaplun A, et al. Raf kinases: function, regulation and role in human cancer. Biochim Biophys Acta 2007;1773:11961212
25. McCubrey JA, Steelman LS, Abrams SL, et al. Emerging MEK inhibitors. Expert Opin Emerg Drugs 2010;15:203-23
26. Roskoski R. RAF protein-serine/ threonine kinases: structure and regulation. Biochem Biophys Res Commun 2010;399:313-17
27. Zhang L, Fu Z, Binkley C, et al. Raf kinase inhibitory protein inhibits beta-cell proliferation. Surgery 2004;136:708-15 (Pubitemid 39186587)
28. Zhang Y, Jiang X, Qin X, et al. RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinoma. Oncogene 2010;295:100-9
29. Schwieger A, Bauer L, Hanusch J, et al. Ras oncogene expression determines sensitivity for intercellular induction ofapoptosis. Carcinogenesis 2001;22:1385-92 (Pubitemid 32898694)
30. Kowluru V, Kowluru RA. Increased oxidative stress in diabetes regulates activation of a small molecular weight G-protein, H-Ras, in the retina. Mol Vis 2007;13:602-10 (Pubitemid 46638505)
31. Cuda G, Paterno R, Candigliota M, et al. Protection of human endothelial cells from oxidative stress: role of Ras-ERK1/2 signaling. Circulation 2002;105:968-74 (Pubitemid 34184576)
32. Urata Y, Yamaguchi M, Higashiyama Y, et al. Reactive oxygen species accelerate production of vascular endothelial growth factor by advanced glycation end products in RAW264.7 mouse macrophages. Free Radic Biol Med 2002;32:688-701 (Pubitemid 34286590)
33. McCubrey JA, Steelman LS, Chappell WH, et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 2007;1777:1263-84 (Pubitemid 47125967)
34. Gurumurthy RK, Maürer AP, Machuy N, et al. A loss-of-function screen reveals Ras- and Raf- independent MEK-ERK signaling during Chlamydia trachomatis infection. Sci. Signal 2010;3:ra21
35. 2+ influx. Functional synergy between Raf and calcineurin. J Immunology 1996;157:5277-83 (Pubitemid 126448944)
36. Sangle GV, Zhao R, Shen GX. Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells. Am J Physiol Endocrinol Metab 2008;295:E1243-54
37. Sangle GV, Zhao R, Mizuno TM, et al. Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells. Endocrinology 2010;151:4455-66
38. Kowluru A, Veluthakal R, Rhodes CJ, et al. Protein farnesylation- dependent Raf/extracellular signal-related kinase signaling links to cytoskeletal remodeling to facilitate glucose-induced insulin secretion in pancreatic beta-cells. Diabetes 2010;59:967-77
39. Reece EA, Wu YK, Zhao Z, et al. Dietary vitamin and lipid therapy rescues aberrant signaling and apoptosis and prevents hyperglycemia-induced diabetic embryopathy in rats. Am J Obstet Gynecol 2006;194:580-5 (Pubitemid 43183719)
40. Kowluru RA, Kowluru A, Kanwar M. Small molecular weight G-protein, H-Ras, and retinal endothelial cell apoptosis in diabetes. Mol Cell Biochem 2007;296:69-76
41. Kanwar M, Chan PS, Kern TS, et al. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci 2007;48:3805-11 (Pubitemid 351261121)
42. Kanwar M, Kowluru RA. Diabetes regulates small molecular weight G-protein, H-Ras, in the microvasculature of the retina: Implication in the development of retinopathy. Microvasc Res 2008;76:189-93
43. Aiello LP. Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. Ophthalmic Res 1997;29:354-62 (Pubitemid 27427368)
44. Gulbins E, Coggeshall KM, Brenner B, et al. Fas-induced apoptosis is mediated by activation of a Ras and Rac protein-regulated signaling pathway. J Biol Chem 1996;271:26389-94 (Pubitemid 26347494)
45. Moorman JP, Gilmer L, Hahn CS, et al. Inactivation of the small G-protein disrupts cellular adhesion and spreading and activates apoptosis. J Inves Med 1996;44:240A (Pubitemid 126817539)
46. Wang CH, Tsai LJ, Tsao YP, et al. Recombinant adenovirus encoding H-ras ribozyme induces apoptosis in laryngeal cancer cells through caspase- and mitochondria-dependent pathways. Biochem Biophys Res Commun 2002;298:805-14
47. Klein C, Creach K, Irintcheva V, et al. Zinc induces ERK-dependent cell death through a specific Ras isoform. Apoptosis 2006;11:1933-44 (Pubitemid 44691577)
48. Zhao Y, Chaiswing L, Bakthavatchalu V, et al. Ras mutation promotes p53 activation and apoptosis of skin keratinocytes. Carcinogenesis 2006;27:1692-8 (Pubitemid 44288059)
49. Singh M, Sharma H, Singh N. Hydrogen peroxide induces apoptosis in HeLa cells through mitochondrial pathway. Mitochondrion 2007;7:367-73 (Pubitemid 350082358)
50. Kowluru RA, Abbas SN. Diabetes-induced mitochondrial dysfunction in the retina. Inves Ophthalmol Vis Sci 2003;44:5327-34 (Pubitemid 37475406)
51. Zhu L, Yu X, Akatsuka Y, et al. Role of mitogen-activated protein kinases in activation-induced apoptosis of T cells. Immunology 1999;97:26-35 (Pubitemid 29217257)
52. Nguyen TT, Tran E, Nguyen TH, et al. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis 2004;25:647-59 (Pubitemid 38618516)
53. Wang X, Martindale JL, Holbrook NJ. Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 2004;275:39435-43
54. Ramos JW. The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int J Biochem Cell Biol 2008;40:2707-19
55. Li AF, Roy S. High glucose-induced downregulation of connexin43 expression promotes apoptosis in microvascular endothelial cells. Invest Ophthalmol Vis Sci 2009;50:1400-7
56. Narasimhan P, Liu J, Song YS, et al. VEGF Stimulates the ERK 1/2 signaling pathway and apoptosis in cerebral endothelial cells after ischemic conditions. Stroke 2009;40:1467-73
57. Romeo G, Liu WH, Asnaghi V, et al. Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 2002;51:2241-8 (Pubitemid 34729031)
58. Kowluru RA, Koppolu P, Chakrabarti S, et al. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic Research 2003;37:1169-80 (Pubitemid 37322195)
59. Zheng L, Szabo C, Kern TS. Poly (ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes 2004;53:2960-7 (Pubitemid 39425922)
60. Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007;2007:95103
61. Moreno-Aspitia A. Clinical overview of sorafenib in breast cancer. Future Oncol 2010;6:655-63
62. Michaelis M, Paulus C, Löschmann N, et al. The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication. Cell Mol Life Sci 2010: published online 30 August 2010, doi: 10.1007/s00018-010-0510-8
63. Oza AM, Elit L, Swenerton K, et al. NCIC Clinical trials group study (NCIC IND.116). Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116). Gynecol Oncol 2003;89:129-33 (Pubitemid 36403659)
64. Jardeleza MS, Miller JW. Review of anti-VEGF therapy in proliferative diabetic retinopathy. Semin Ophthalmol 2010;24:87-92
65. Hnik P, Boyer DS, Grillone LR, et al. Antisense oligonucleotide therapy in diabetic retinopathy. J Diabetes Sci Technol 2009;3:924-30
66. Sudhakar A, Nyberg P, Keshamouni VG, et al. Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin. J Clin Invest 2005;115:2801-10 (Pubitemid 41434407)
67. Potenza MA, Gagliardi S, Nacci C, et al. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem 2009;16:94-112
68. Gu W, Putral LN, Irving A, et al. The development and future of oligonucleotide-based therapies for cervical cancer. Curr Opin Mol Ther 2007;9:126-31 (Pubitemid 46623944)
69. Holtmann MH, Neurath MF. From immunogenic mechanisms to novel therapeutic approaches in inflammatory bowel disease. Adv Exp Med Biol 2006;579:227-42
70. Danis RP, Henry SP, Ciulla TA. Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases. Exp Opin Pharmacotherapy 2001;2:277-91 (Pubitemid 32427731)
71. Yamamot H. Mechanisms of vascular injury in diabetes: lessons from vascular cells in culture and transgenic animals. Biomed Rev 2000;11:19-27
72. Helene C. Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides. Eur J Cancer 1991;27:1466-71
73. Roy S, Sato T, Paryani G, et al. Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. Diabetes 2003;52:1229-34 (Pubitemid 36523361)
74. Wilkinson-Berka JL, Wraight C, Werther G. The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy. Curr Med Chem 2006;13:3307-17 (Pubitemid 44669777)
75. Harris MI. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 1993;16:642-52 (Pubitemid 23097217)